Summary
Ein entfernter, anonymer oder authentisierter Angreifer kann mehrere Schwachstellen in Oracle Health Sciences Applications ausnutzen, um die Vertraulichkeit, Integrität und Verfügbarkeit zu gefährden.
Product
Health Sciences Applications ist eine Zusammenstellung von Produkten für die Pharma-, Biotechnologie-, Medizin- und Gesundheitsbranche.
Vulnerabilities 5
-
Medium 6.5
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: P…
-
Medium 6.5
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: P…
-
Medium 6.5
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Pla…
-
Medium 5.5
InstallShield Symlink Vulnerability Affecting Suite Project Setups
A vulnerability has been reported in Suite Setups built with versions prior to InstallShield 2023 R2. This vulnerability may allow locally authenticated users to cause a Denial of Service (DoS) condition when handling move operations on local, temporary folde…
-
Medium 5.3
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: P…
Revision history
-
#1
Initiale Fassung
References
-
Oracle Critical Patch Update Advisory - January 2026 - Appendix Oracle Health Sciences Applications vom 2026-01-20
https://www.oracle.com/security-alerts/cpujan2026.html#AppendixHCAR